5. Disease / Application Areas

gene therapy

Definition

Gene therapy is a therapeutic approach that involves introducing, altering, or replacing genetic material within a patient's cells to treat or prevent disease. This technique can work through several mechanisms: replacing mutated genes with functional copies, inactivating disease-causing genes, or introducing new genes to help fight disease. Gene therapy encompasses various delivery methods, including viral vectors (adenoviruses, lentiviruses, AAV), non-viral vectors (liposomes, nanoparticles), and direct injection. Applications range from treating monogenic disorders like sickle cell disease and hemophilia to complex conditions including cancer and cardiovascular disease. The approach has evolved from ex vivo methods (modifying cells outside the body) to in vivo delivery (direct administration to patients), with CRISPR-based therapies representing the latest frontier in precision gene editing.

Visualize gene therapy in Nodes Bio

Researchers can use Nodes Bio to map gene therapy target pathways, visualizing how therapeutic gene insertions affect downstream signaling cascades and protein interaction networks. Network analysis reveals off-target effects, compensatory pathways, and potential resistance mechanisms. Users can model vector tropism patterns, track transgene expression through regulatory networks, and identify biomarkers for patient stratification by connecting genetic variants to phenotypic outcomes across multi-omics datasets.

Visualization Ideas:

  • Gene therapy target pathway networks showing therapeutic gene insertion points and downstream effects
  • Viral vector tropism maps connecting vector types to tissue-specific receptor expression patterns
  • Off-target effect networks linking therapeutic genes to unintended pathway activations and potential adverse events
Request Beta Access →

Example Use Case

A research team developing AAV-based gene therapy for Duchenne muscular dystrophy uses network visualization to optimize their approach. They map the dystrophin protein interaction network to identify which protein complexes are disrupted by DMD mutations. By visualizing the connections between dystrophin, the dystrophin-glycoprotein complex, and downstream signaling pathways involved in muscle fiber integrity, they identify critical nodes that must be restored. The network analysis reveals compensatory pathways activated in patient cells and helps predict which patients might respond best based on their specific mutation profiles and residual pathway activity.

Related Terms

Ready to visualize your research?

Join researchers using Nodes Bio for network analysis and visualization.

Request Beta Access